Patients The unexpected starting line: Solving drug affordability at ... In early 2025, the White House renewed its push to lower prescription drug prices, part of an executive order aimed at easing patients' financial burdens.
News Makary, Prasad set out their vision for the FDA Top FDA officials have spelled out their strategic priorities in the coming years, including the use of AI to "increase efficiency."
News First details of Trump's most favoured nation plan emerge Donald Trump's plan to introduce a most favoured nation (MFN) system of drug pricing controls is not quite what he first said it would be.
News Update: Trump 'will tie US drug prices to other countries' President Donald Trump said he will sign an order today to cut prescription drug prices in the US to the level paid by other comparable countries.
News Spectre of 'favoured nation' pricing manifests again in US President Trump is rumoured to be resurrecting a policy that would see drug prices offered to federal programmes tied to those offered overseas.
Market Access Unpacking Trump’s executive order on drug pricing, with Alic... Jonah Comstock welcomed back Alice Valder Curran to the podcast to pick apart Trump's Executive Order order piece by piece.
News Remepy's hybrid Parkinson's therapy poised for phase 3 Remepy's Hybridopa therapy for Parkinson's, which combines an app with levodopa therapy, has shown efficacy in a phase 2 pilot study.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.